These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 11259560)
1. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. Venkatakrishnan K; von Moltke LL; Greenblatt DJ J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560 [TBL] [Abstract][Full Text] [Related]
2. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589 [TBL] [Abstract][Full Text] [Related]
3. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related]
4. Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism. Störmer E; von Moltke LL; Greenblatt DJ J Pharmacol Exp Ther; 2000 Nov; 295(2):793-801. PubMed ID: 11046120 [TBL] [Abstract][Full Text] [Related]
5. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4. Venkatakrishnan K; Greenblatt DJ; von Moltke LL; Schmider J; Harmatz JS; Shader RI J Clin Pharmacol; 1998 Feb; 38(2):112-21. PubMed ID: 9549641 [TBL] [Abstract][Full Text] [Related]
6. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Mutch E; Williams FM Toxicology; 2006 Jul; 224(1-2):22-32. PubMed ID: 16757081 [TBL] [Abstract][Full Text] [Related]
7. Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies. Venkatakrishnan K; Schmider J; Harmatz JS; Ehrenberg BL; von Moltke LL; Graf JA; Mertzanis P; Corbett KE; Rodriguez MC; Shader RI; Greenblatt DJ J Clin Pharmacol; 2001 Oct; 41(10):1043-54. PubMed ID: 11583471 [TBL] [Abstract][Full Text] [Related]
8. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479 [TBL] [Abstract][Full Text] [Related]
9. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Shimada T; Tsumura F; Yamazaki H Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312 [TBL] [Abstract][Full Text] [Related]
10. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Roy P; Yu LJ; Crespi CL; Waxman DJ Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794 [TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Picard N; Cresteil T; Djebli N; Marquet P Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975 [TBL] [Abstract][Full Text] [Related]
12. Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research. Masimirembwa CM; Otter C; Berg M; Jönsson M; Leidvik B; Jonsson E; Johansson T; Bäckman A; Edlund A; Andersson TB Drug Metab Dispos; 1999 Oct; 27(10):1117-22. PubMed ID: 10497136 [TBL] [Abstract][Full Text] [Related]
13. Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450. Chen Y; Liu L; Nguyen K; Fretland AJ Drug Metab Dispos; 2011 Mar; 39(3):373-82. PubMed ID: 21148079 [TBL] [Abstract][Full Text] [Related]
14. In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. Warrington JS; Shader RI; von Moltke LL; Greenblatt DJ Drug Metab Dispos; 2000 Apr; 28(4):392-7. PubMed ID: 10725306 [TBL] [Abstract][Full Text] [Related]
15. Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate. Suzuki A; Iida I; Tanaka F; Akimoto M; Fukushima K; Tani M; Ishizaki T; Chiba K Drug Metab Dispos; 1999 Nov; 27(11):1254-9. PubMed ID: 10534309 [TBL] [Abstract][Full Text] [Related]
16. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine. Kudo S; Okumura H; Miyamoto G; Ishizaki T Drug Metab Dispos; 1999 Feb; 27(2):303-8. PubMed ID: 9929520 [TBL] [Abstract][Full Text] [Related]
18. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities. Doehmer J; Weiss G; McGregor GP; Appel K Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450. Shou M; Krausz KW; Gonzalez FJ; Gelboin HV Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931 [TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites. Avent KM; DeVoss JJ; Gillam EM Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]